Chfr interacts and colocalizes with TCTP to the mitotic spindle

Oncogene

Volumn 27, Issue 42, 2008, Pages 5554-5566

  Burgess, A ^a   Labbe J C ^a   Vigneron, S ^a   Bonneaud, N ^b   Strub, J M ^c   Van Dorsselaer, A ^c   Lorca, T ^a,d   Castro, A ^a,d  

^a Centre National de la Recherche Scientifique   (France)

^b INSTITUTE OF HUMAN GENETICS   (France)

^c INSTITUT DE RECHERCHES SUBATOMIQUES   (France)

^d UNIV MONTPELLIER   (France)

Author keywords

Cancer; Checkpoint; Chfr; Prophase; Spindle; TCTP

Indexed keywords

BETA TUBULIN; CHFR PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEASOME; PROTEIN ANTIBODY; PROTEIN DERIVATIVE; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DEPOLYMERIZATION; FEMALE; HUMAN; HUMAN CELL; MICROTUBULE; MITOSIS SPINDLE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; TWO HYBRID SYSTEM; UBIQUITINATION;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; HELA CELLS; HUMANS; MICROTUBULES; MITOTIC SPINDLE APPARATUS; NEOPLASM PROTEINS; PHOSPHORYLATION; TUBULIN; TUMOR MARKERS, BIOLOGICAL; UBIQUITINATION; XENOPUS;

EID: 52149123920     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.167     Document Type: Article

References (31)

1. Abrieu A, Magnaghi-Jaulin L, Kahana J, Peter M, Castro A, Vigneron S et al. (2001). Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint. Cell 106: 83-93.
2. Bothos J, Summers M, Venere M, Scolnick D, Halazonetis T. (2003). The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form Lys63-linked polyubiquitin chains. Oncogene 22: 7101-7107.
3. Burgess A, Wigan M, Giles N, Depinto W, Gillespie P, Stevens F et al. (2006). Inhibition of S/G2 phase CDK4 reduces mitotic fidelity. J Biol Chem 281: 9987-9995.
4. Chaturvedi P, Sudakin V, Bobiak M, Fisher P, Mattern M, Jablonski S et al. (2002). Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity. Cancer Res 62: 1797-1801.
5. Cheung H, Toyota M, Ching Y, Sasaki Y, Nicholls J, Satoh A et al. (2003). Epigenetic inactivation of CHFR in human tumors. Proc Natl Acad Sci USA 100: 7818-7823.
6. Corn P, Summers M, Fogt F, Virmani A, Gazdar A, Halazonetis T et al. (2003). Frequent hypermethylation of the 5′ CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer. Carcinogenesis 24: 47-51.
7. Daniels M, Marson A, Venkitaraman A. (2004). PML bodies control the nuclear dynamics and function of the CHFR mitotic checkpoint protein. Nat Struct Mol Biol 11: 1114-1121.
8. Erson A, Petty E. (2003). CHFR-associated early G2/M checkpoint defects in breast cancer cells. Mol Carcinog 39: 26-33.
9. Fromont-Racine M, Rain JC, Legrain P. (1997). Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens. Nat Genet 16: 277-282.
10. Gabrielli B, De Souza C, Tonks I, Clark J, Hayward N, Ellem K. (1996). Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. J Cell Sci 109(Part 5): 1081-1093.
11. Gachet Y, Tournier S, Lee M, Lazaris-Karatzas A, Poulton T, Bommer U. (1999). The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. J Cell Sci 112(Part 8): 1257-1271.
12. Hsu Y, Chern J, Cai Y, Liu M, Choi K. (2007). Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase. Nature 445: 785-788.
13. Jung J, Kim M, Kim M, Kim J, Moon J, Lim J et al. (2004). Translationally controlled tumor protein interacts with the third cytoplasmic domain of Na,K-ATPase alpha subunit and inhibits the pump activity in HeLa cells. J Biol Chem 279: 49868-49875.
14. Kang D, Chen J, Wong J, Fang G. (2002). The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition. J Cell Biol 156: 249-259.
15. Liu H, Peng H, Cheng Y, Yuan H, Yang-Yen H. (2005). Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol Cell Biol 25: 3117-3126.
16. Loring GL, Christensen KC, Gerber SA, Brenner C. (2008). Yeast Chfr homologs retard cell cycle at G1 and G2/M via Ubc4 and Ubc13/Mms2-dependent ubiquitination. Cell Cycle 7: 96-105.
17. Mariatos G, Bothos J, Zacharatos P, Summers M, Scolnick D, Kittas C et al (2003). Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer. Cancer Res 63: 7185-7189.
18. Matsusaka T, Pines J. (2004). Chfr acts with the p38 stress kinases to block entry to mitosis in mammalian cells. J Cell Biol 166: 507-516.
19. Mikhailov A, Shinohara M, Rieder C. (2004). The p38-mediated stress-activated checkpoint. A rapid response system for delaying progression through antephase and entry into mitosis. Cell Cycle 4: 57-62.
20. Mizuno K, Osada H, Konishi H, Tatematsu Y, Yatabe Y, Mitsudomi T et al. (2002). Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers. Oncogene 21: 2328-2333.
21. Murray AW, Kirschner MW. (1991). What controls the cell cycle? Sci Am 264: 56-63.
22. Privette L, González M, Ding L, Kleer C, Petty E. (2007). Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression. Cancer Res 67: 6064-6074.
23. Rieder C, Cole R. (2000). Microtubule disassembly delays the G2-M transition in vertebrates. Curr Biol 10: 1067-1070.
24. Satoh A, Satoh A, Toyota M, Toyota M, Itoh F, Itoh F et al. (2003). Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer. Cancer Res 63: 8606-8613.
25. Scolnick D, Halazonetis T. (2000). Chfr defines a mitotic stress checkpoint that delays entry into metaphase. Nature 406: 430-435.
26. Tuynder M, Fiucci G, Prieur S, Lespagnol A, Géant A, Beaucourt S et al. (2004). Translationally controlled tumor protein is a target of tumor reversion. Proc Natl Acad Sci USA 101: 15364-15369.
27. Tuynder M, Susini L, Prieur S, Besse S, Fiucci G, Amson R et al. (2002). Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1. Proc Natl Acad Sci USA 99: 14976-14981.
28. Uzbekov R, Chartrain I, Philippe M, Arlot-Bonnemains Y. (1998). Cell cycle analysis and synchronization of the Xenopus cell line XL2. EMBO Rep 242: 60-68.
29. Yang Y, Yang F, Xiong Z, Yan Y, Wang X, Nishino M et al. (2005). An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity. Oncogene 24: 4778-4788.
30. Yarm F. (2002). Plk phosphorylation regulates the microtubule-stabilizing protein TCTP. Mol Cell Biol 22: 6209-6221.
31. Yu X, Minter-Dykhouse K, Malureanu L, Zhao W, Zhang D, Merkle C et al. (2005). Chfr is required for tumor suppression and aurora a regulation. Nat Genet 37: 401-406.